Breast Cancer - Carcinogenesis, Cell Growth and Signalling Pathways 2011
DOI: 10.5772/23788
|View full text |Cite
|
Sign up to set email alerts
|

Engineering Transcription Factors in Breast Cancer Stem Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2013
2013
2015
2015

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 139 publications
(164 reference statements)
0
2
0
Order By: Relevance
“…We previously found that Trp53 , Bmp7 , Ctnnb1 , and Bmp10 identified Ingenuity canonical pathways for basal cell carcinoma signaling and role of NANOG in mammalian embryonic stem cell pluripotency [ 6 ]. This suggests that the similarity between HFD early tumors and basal-like breast cancer [ 23 ] is reiterated in the HFD-LFD early tumors. In our prior studies [ 6 ], Trp53 , Ctnnb1 , Ccnd2, Brca1 , and Apaf1 also identified Ingenuity canonical pathways for p53 signaling and GADD45 signaling.…”
Section: Discussionmentioning
confidence: 99%
“…We previously found that Trp53 , Bmp7 , Ctnnb1 , and Bmp10 identified Ingenuity canonical pathways for basal cell carcinoma signaling and role of NANOG in mammalian embryonic stem cell pluripotency [ 6 ]. This suggests that the similarity between HFD early tumors and basal-like breast cancer [ 23 ] is reiterated in the HFD-LFD early tumors. In our prior studies [ 6 ], Trp53 , Ctnnb1 , Ccnd2, Brca1 , and Apaf1 also identified Ingenuity canonical pathways for p53 signaling and GADD45 signaling.…”
Section: Discussionmentioning
confidence: 99%
“…Provocatively, altered expression of a partially overlapping set of genes, Trp53 , Bmp7 , Ctnnb1 , and Bmp10 , identified the Basal Cell Carcinoma signaling and Role of NANOG in Mammalian Stem Cell Pluripotency pathways. This suggests similarity between the HFD-E tumors and breast tumors displaying stem and/or progenitor cell characteristics, such as basal-like breast cancer [ 81 ]. The downregulation of luminal epithelial makers, Krt8 and 18, in HFD-E tumors is also consistent with this.…”
Section: Discussionmentioning
confidence: 99%